CAPTRUST Financial Advisors
STRO icon

CAPTRUST Financial Advisors’s Sutro Biopharma STRO Stock Holding History

CAPTRUST Financial Advisors’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,100
Closed -$7.85K – 2713
2025
Q2 		$7.85K Buy
+1,100
New +$8.99K ﹤0.01% 2503
2022
Q3 		– Sell
-12
Closed -$1K – 3814
2022
Q2 		$1K Sell
12
-28
-70% -$1.56K ﹤0.01% 4748
2022
Q1 		$3K Buy
40
+34
+567% +$3.23K ﹤0.01% 4392
2021
Q4 		$1K Hold
6
– – ﹤0.01% 4629
2021
Q3 		$1K Hold
6
– – ﹤0.01% 4482
2021
Q2 		$1K Sell
6
-1
-14% -$196 ﹤0.01% 4387
2021
Q1 		$2K Buy
+7
New +$1.66K ﹤0.01% 4076

Other funds holding STRO

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

CAPTRUST Financial Advisors's STRO Position: Q3 2025 in Review

CAPTRUST Financial Advisors sold out of Sutro Biopharma (STRO) in Q3 2025, closing a stake of 1,100 shares — an estimated $7.85K sold.

CAPTRUST Financial Advisors first reported a position in STRO in Q1 2021 and held it in 7 quarters. The position peaked at $7.85K in Q2 2025. 87 funds tracked by Wall St. Rank hold STRO as of Q3 2025.

  • CAPTRUST Financial Advisors reported no remaining Sutro Biopharma position as of Q3 2025 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 1,100 Sutro Biopharma shares in Q3 2025, an estimated $7.85K.
  • CAPTRUST Financial Advisors first reported a position in Sutro Biopharma in Q1 2021 and held it in 7 quarters.
  • CAPTRUST Financial Advisors's Sutro Biopharma position peaked at $7.85K in Q2 2025.
  • 87 funds tracked by Wall St. Rank held Sutro Biopharma as of Q3 2025.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2025, filed 19 Nov 2025.